When Will Moderna Stock Be a Screaming Buy?
Moderna (NASDAQ: MRNA) is now far below its peak market cap last summer of nearly $200 billion. But when will the vaccine stock be a screaming buy for investors? In this Motley Fool Live video recorded on Jan. 5, Fool contributors Keith Speights and Brian Orelli discuss how low Moderna needs to go to make the stock a clear bargain.
Source Fool.com